To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C16orf87TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
177 supporting clones for gene C16orf87 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI562429 testis .a 1 to 858 1 to 873 R3G K137N E138R S140V A141S ... tiling clone,   873/893
(97 %)
36 diff
(96.0 %id)
TI_44350316   .a 6 to 858 130 to 997       868/1017
(85 %)
39 diff
(96.2 %id)
AW161150 brain, frontal lobe .b 1 to 528 1 to 528   tiling clone,   528/528
(100 %)
0 diff
(100 %id)
AA432236   .b 15 to 458 11 to 453       443/453
(97 %)
6 diff
(98.7 %id)
AW161369 brain, frontal lobe .b 15 to 454 1 to 440       440/449
(97 %)
5 diff
(98.9 %id)
AW162839 brain, frontal lobe .b 15 to 443 1 to 429       429/429
(100 %)
0 diff
(100 %id)
AW162074 brain, frontal lobe .b 15 to 433 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
AW163367 brain, frontal lobe .b 15 to 571 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
TI_57241360   .b 15 to 795 27 to 805 exact     779/819
(95 %)
13 diff
(98.5 %id)
BI913735 brain .b 19 to 795 1 to 775 exact     775/789
(98 %)
8 diff
(99.0 %id)
BG530965 embryonal carcinoma, testis .b 32 to 729 1 to 701 K79N D80R L81F E82R N83K ...     701/701
(100 %)
5 diff
(99.3 %id)
BG723499 testis .b 48 to 790 1 to 746 K85Q E114R R115K E116R K117E ...     746/762
(97 %)
13 diff
(98.3 %id)
DN992270 brain, whole brain .b 62 to 645 7 to 590 exact     584/590
(98 %)
6 diff
(99.0 %id)
CK819225 Islets of Langerhans, Pancreas .b 67 to 648 1 to 582 exact     582/582
(100 %)
1 diff
(99.9 %id)
BI258938 cervical carcinoma cell line, cervix .b 69 to 890 1 to 828 exact     806/828
(97 %)
20 diff
(97.6 %id)
BF215230 bone marrow, from acute myelogenous leukemia .b 72 to 775 1 to 713 R115T E116R K117E Q118H E119Q ...     711/759
(93 %)
26 diff
(96.6 %id)
BG531898 embryonal carcinoma, testis .b 72 to 696 1 to 621 T4A     621/621
(100 %)
8 diff
(98.8 %id)
DN918850   .b 74 to 588 1 to 516 H46R A141T     516/517
(99 %)
8 diff
(98.5 %id)
CN341896 embryonic stem cells, DMSO-treated H9 cellline .b 75 to 319 1 to 245       245/245
(100 %)
0 diff
(100 %id)
BF217855 brain, glioblastoma .b 76 to 764 1 to 677 A26H C27V K28N S29H C30V ...     677/889
(76 %)
24 diff
(97.4 %id)
BF219238 brain, glioblastoma .b 77 to 772 1 to 717 A26H C27V K28N S29H C30V ...     621/838
(74 %)
35 diff
(95.9 %id)
BF218734 brain, glioblastoma .b 77 to 790 1 to 719 R98E G99E R100E G101E R102D ...     719/891
(80 %)
47 diff
(94.8 %id)
BF673397 Prostate .b 77 to 839 1 to 763 A108X K109Q H111T E112* AAA   763/763
(100 %)
31 diff
(96.0 %id)
CX785873 human embryonic stem cells .b 77 to 844 29 to 788 V23I A106S     627/826
(75 %)
49 diff
(94.1 %id)
FN108968 breast carcinoma .b 78 to 150 1 to 72       72/72
(100 %)
3 diff
(95.9 %id)
AI635410 pooled germ cell tumors .b 79 to 325 423 to 177       247/423
(58 %)
0 diff
(100 %id)
BG150253 pooled germ cell tumors .b 79 to 325 433 to 187       247/433
(57 %)
2 diff
(99.6 %id)
BF211430 bone marrow, from chronic myelogenous leukemia .b 80 to 631 1 to 558 K120T E121G I122N D123*     558/558
(100 %)
7 diff
(98.8 %id)
BF212475 bone marrow, from chronic myelogenous leukemia .b 80 to 711 1 to 626 A26H C27V K28N S29H C30V ...     626/628
(99 %)
9 diff
(98.6 %id)
BG399134 Kidney .b 80 to 708 1 to 631 exact     631/632
(99 %)
4 diff
(99.4 %id)
CD688875 normal nasopharynx .b 81 to 653 36 to 608 L140S     573/608
(94 %)
8 diff
(98.7 %id)
BU930716 Prostate .b 81 to 846 1 to 773 exact     773/773
(100 %)
15 diff
(98.1 %id)
BE622073 melanotic melanoma, skin .b 83 to 787 1 to 703 K120P E121G I122N D123*     703/846
(83 %)
11 diff
(98.7 %id)
BF213722 bone marrow, from acute myelogenous leukemia .b 83 to 681 1 to 596 D123G L140W A141Q E142K I143*     596/868
(68 %)
18 diff
(98.0 %id)
BM128201 Islets of Langerhans, Pancreas .b 83 to 648 1 to 566 exact     566/566
(100 %)
1 diff
(99.9 %id)
BF244547 brain, glioblastoma .b 86 to 741 1 to 649 V138R A139R A141G E142R I143N ...     649/868
(74 %)
14 diff
(98.4 %id)
CN341895 embryonic stem cells, cell lines H1, H7, andH9 .b 87 to 698 13 to 623 K7R V9*     611/623
(98 %)
6 diff
(99.1 %id)
BG612953 embryonal carcinoma, testis .b 87 to 766 1 to 681 H92R N144T R145*     681/681
(100 %)
2 diff
(99.8 %id)
BG940540 blood .b 92 to 478 1 to 387       387/387
(100 %)
1 diff
(99.8 %id)
BC056676 Pooled, 40 cell lines .b 92 to 1478 1 to 1387 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1387/1388
(99 %)
4 diff
(99.8 %id)
BU940838 mixed (pool of 40 RNAs) .b 93 to 547 1 to 457       457/879
(51 %)
6 diff
(99.4 %id)
BG501851 embryonal carcinoma, testis .b 95 to 787 1 to 706 N74K S75F T76Y V77S N78D ...     706/716
(98 %)
27 diff
(96.3 %id)
NM_001001436.2   .b 96 to 1479 1 to 1384 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1384/1384
(100 %)
1 diff
(100.0 %id)
BF208867 bladder, carcinoma, cell line .b 99 to 694 1 to 608 A26H C27V K28N S29H C30V ...     608/802
(75 %)
40 diff
(95.1 %id)
TI_44349040   .b 100 to 873 117 to 903 K120T E121G I122T D123L I124T ...     713/905
(78 %)
28 diff
(97.0 %id)
BI560393 testis .b 104 to 873 1 to 784 K120T E121G I122T D123L I124T ...     710/786
(90 %)
25 diff
(96.9 %id)
N31672 melanocyte .b 106 to 517 1 to 421       419/521
(80 %)
8 diff
(98.5 %id)
CN341893 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 107 to 776 8 to 678 exact     671/683
(98 %)
8 diff
(98.9 %id)
EL735860 mixed .b 109 to 572 1 to 464       464/625
(74 %)
1 diff
(99.9 %id)
CB270325 adipose .b 110 to 694 1 to 584       584/586
(99 %)
5 diff
(99.2 %id)
BE564878 bladder, carcinoma, cell line .b 115 to 778 1 to 665       665/820
(81 %)
30 diff
(96.4 %id)
DA892877 skeletal muscle .b 128 to 991 2 to 869   capped   868/868
(100 %)
18 diff
(98.0 %id)
BF700722 brain, primitive neuroectoderm .b 134 to 844 1 to 699       699/849
(82 %)
30 diff
(96.5 %id)
CN341892 embryonic stem cells, DMSO-treated H9 cellline .b 150 to 815 1 to 666       666/666
(100 %)
0 diff
(100 %id)
BG614112 embryonal carcinoma, testis .b 174 to 1010 1 to 822       822/966
(85 %)
12 diff
(98.8 %id)
CR622077 Neuroblastoma Cot 25-normalized .b 200 to 1447 1 to 1248       1248/1248
(100 %)
0 diff
(100 %id)
BX332462 Neuroblastoma Cot 25-normalized .b 200 to 1127 1 to 916   fully sequenced, AAA   916/916
(100 %)
0 diff
(100 %id)
AA397880   .b 221 to 485 1 to 265   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
BM796892 Ascites, stomach .b 249 to 814 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BF793273 adrenal cortex carcinoma, cell line, adrenal gland .b 252 to 718 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
CN341894 embryonic stem cells, DMSO-treated H9 cellline .b 256 to 720 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
BU561339 testis .b 366 to 1128 1 to 778       778/856
(90 %)
31 diff
(96.4 %id)
BU569419 testis .b 366 to 1133 1 to 777       777/796
(97 %)
42 diff
(94.8 %id)
C02242   .b 388 to 532 1 to 145       145/146
(99 %)
2 diff
(98.7 %id)
AA435821   .b 427 to 829 403 to 1   fully sequenced,   403/403
(100 %)
0 diff
(100 %id)
AI935434 Kidney .b 440 to 829 390 to 1       390/390
(100 %)
6 diff
(98.5 %id)
AW157311 brain, frontal lobe .b 649 to 1289 641 to 1       641/641
(100 %)
0 diff
(100 %id)
AW156889 brain, frontal lobe .b 691 to 1289 599 to 1       599/599
(100 %)
0 diff
(100 %id)
AW162731 brain, frontal lobe .b 807 to 1289 483 to 1       483/483
(100 %)
5 diff
(99.0 %id)
AW161825 brain, frontal lobe .b 827 to 1289 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AW157470 brain, frontal lobe .b 842 to 1289 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AA428619   .b 1037 to 1481 446 to 2       445/446
(99 %)
0 diff
(100 %id)
BX332461 Neuroblastoma Cot 25-normalized .b 1097 to 1447 352 to 1   fully sequenced,   352/352
(100 %)
1 diff
(99.8 %id)
DB460878 testis .c 1 to 397 1 to 397 G2D tiling clone,   397/397
(100 %)
1 diff
(99.8 %id)
BI911607 leukocyte .d 1 to 664 35 to 728 A12D E18*     691/751
(92 %)
39 diff
(94.9 %id)
TI_57233003   .d 1 to 664 35 to 728 A12D E18* tiling clone,   691/751
(92 %)
39 diff
(94.9 %id)
CX165539 human embryonic stem cells differentiated toan early endodermal cell type .d 169 to 857 1 to 689 exact tiling clone,   689/689
(100 %)
0 diff
(100 %id)
BF185345 bone marrow, from chronic myelogenous leukemia .d 187 to 739 1 to 566 Y34S I35H F36I I37Y S38*     566/931
(60 %)
25 diff
(97.4 %id)
TI_57176780   .d 187 to 857 65 to 733 L79W A80Q E81K I82*     669/734
(91 %)
10 diff
(98.7 %id)
BI829522 brain, medulla .d 191 to 857 1 to 665 L79W A80Q E81K I82*     665/666
(99 %)
6 diff
(99.1 %id)
AW239372 lung, cell line .d 201 to 726 1 to 526 exact     526/526
(100 %)
0 diff
(100 %id)
BF667552 brain, primitive neuroectoderm .d 214 to 775 1 to 566 I61M D62T I63S Y64M A65L ...     566/815
(69 %)
19 diff
(97.7 %id)
CN370297 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 218 to 858 1 to 642 exact     642/647
(99 %)
3 diff
(99.6 %id)
DN915097   .d 224 to 826 1 to 601 exact     601/601
(100 %)
6 diff
(99.1 %id)
BG399732 Kidney .d 224 to 908 1 to 685 exact     685/688
(99 %)
9 diff
(98.7 %id)
BG497715 adenocarcinoma, Prostate .d 227 to 858 1 to 628 K10Q     628/628
(100 %)
8 diff
(98.8 %id)
BG430762 Kidney .d 236 to 878 1 to 648 F75X L93S     648/649
(99 %)
24 diff
(96.4 %id)
BF695606 brain, primitive neuroectoderm .d 237 to 754 1 to 518 K59T I61M F73S F75L S76Q ...     518/764
(67 %)
20 diff
(97.4 %id)
DR159378 human embryonic stem cells differentiated toan early endodermal cell type .d 242 to 1006 1 to 766 exact     766/766
(100 %)
1 diff
(99.9 %id)
BF132587 lung, mucoepidermoid carcinoma .d 244 to 875 1 to 628 V25R I61M D62T I63S Y64M ...     628/628
(100 %)
16 diff
(97.5 %id)
BX647945 endometrium carcinoma cell line .d 246 to 6885 1 to 6638 exact tiling clone, available from DKFZ,   6638/6646
(99 %)
16 diff
(99.8 %id)
BU507782 leiomyosarcoma, uterus .d 263 to 1049 1 to 800       800/920
(86 %)
21 diff
(97.8 %id)
CB955968 Pooled-Glandular .d 275 to 842 1 to 574       574/808
(71 %)
24 diff
(97.1 %id)
BG208226   .d 416 to 1079 1 to 659       659/1099
(59 %)
33 diff
(97.0 %id)
BG183345   .d 417 to 1002 1 to 588       588/766
(76 %)
35 diff
(95.5 %id)
BG209312   .d 421 to 1229 6 to 806       801/808
(99 %)
23 diff
(97.2 %id)
H11695 whole brain .d 422 to 911 1 to 497       497/497
(100 %)
14 diff
(97.2 %id)
CN370299 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 431 to 850 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
AW510965 pooled .d 551 to 1083 533 to 1       533/533
(100 %)
3 diff
(99.5 %id)
TI_154000737   .d 586 to 1132 633 to 87   AAA   547/970
(56 %)
3 diff
(99.7 %id)
AA029494 heart .d 615 to 796 182 to 1       182/182
(100 %)
0 diff
(100 %id)
CA432910 mixed .d 631 to 1132 513 to 12   AAA   502/502
(100 %)
1 diff
(99.9 %id)
CN370298 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 647 to 1249 1 to 603   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 603/603
(100 %)
0 diff
(100 %id)
FN100422 breast carcinoma .d 670 to 758 89 to 1     Submitted on the opposite strand 89/105
(84 %)
0 diff
(100 %id)
BQ007535 Chondrosarcoma, Left Pubic Bone .d 739 to 1455 732 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
AA093567   .d 743 to 963 1 to 215       215/217
(99 %)
10 diff
(95.4 %id)
N55693   .d 743 to 944 1 to 204       204/207
(98 %)
12 diff
(94.3 %id)
BQ014915 Chondrosarcoma, Left Pubic Bone .d 745 to 1455 726 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 708/708
(100 %)
4 diff
(99.5 %id)
AI743127 pooled .d 796 to 1249 472 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 454/455
(99 %)
4 diff
(99.2 %id)
N23201 melanocyte .d 797 to 1249 456 to 1       456/456
(100 %)
3 diff
(99.4 %id)
BU569518 testis .d 832 to 1455 1 to 624       624/850
(73 %)
6 diff
(99.3 %id)
AI242243 ovary, tumor, 5 pooled (see description) .d 842 to 1249 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA733100 heart .d 850 to 1130 281 to 1       281/281
(100 %)
0 diff
(100 %id)
CF994549 Human Placenta, placenta .d 857 to 1562 27 to 725       699/733
(95 %)
6 diff
(99.2 %id)
BF431903 pooled .d 893 to 1448 557 to 2       556/557
(99 %)
0 diff
(100 %id)
CK819224 Islets of Langerhans, Pancreas .d 902 to 1455 578 to 25   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 554/554
(100 %)
5 diff
(99.1 %id)
AW183053 pooled .d 910 to 1448 541 to 2       540/541
(99 %)
0 diff
(100 %id)
H96793 melanocyte .d 958 to 1249 292 to 1       292/292
(100 %)
0 diff
(100 %id)
AI991455 Kidney .d 959 to 1249 292 to 1       292/292
(100 %)
1 diff
(99.7 %id)
AA383023 testis .d 961 to 1232 1 to 272       272/272
(100 %)
0 diff
(100 %id)
FN052842 breast carcinoma .d 976 to 1063 88 to 1     Submitted on the opposite strand 88/89
(98 %)
1 diff
(98.9 %id)
DN915096   .d 977 to 1441 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
BM127897 Islets of Langerhans, Pancreas .d 999 to 1455 481 to 25   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 457/457
(100 %)
6 diff
(98.7 %id)
AI125866   .d 1000 to 1446 481 to 35   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
AW195476 Kidney .d 1000 to 1448 453 to 4       450/453
(99 %)
0 diff
(100 %id)
AW513383 colon, juvenile granulosa tumor .d 1000 to 1446 447 to 1       447/447
(100 %)
2 diff
(99.6 %id)
AW615191 Kidney .d 1000 to 1458 459 to 1       459/459
(100 %)
0 diff
(100 %id)
DB526275 testis .d 1014 to 1445 1 to 432     Submitted on the opposite strand 432/433
(99 %)
1 diff
(99.8 %id)
D61731   .d 1016 to 1362 1 to 344       344/344
(100 %)
5 diff
(98.6 %id)
AW236054 Kidney .d 1018 to 1446 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
AI859089 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1026 to 1456 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AW614834 Kidney .d 1026 to 1446 421 to 1       421/421
(100 %)
3 diff
(99.3 %id)
AW083531 colon, moderately differentiated adenocarcinoma .d 1028 to 1447 418 to 1       418/418
(100 %)
3 diff
(99.3 %id)
AI247764 liver and spleen .d 1029 to 1451 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
CA337947 1st pharyngeal arch (pooled) .d 1048 to 1464 1 to 418       418/436
(95 %)
10 diff
(97.8 %id)
AL706567 human skeletal muscle .d 1101 to 1760 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
AL706591 human skeletal muscle .d 1101 to 1445 1 to 345       345/345
(100 %)
13 diff
(96.3 %id)
H11606 whole brain .d 1119 to 1446 337 to 9       329/337
(97 %)
0 diff
(100 %id)
AI470958 Kidney .d 1155 to 1457 303 to 1       303/303
(100 %)
0 diff
(100 %id)
BG940541 blood .d 1164 to 1458 320 to 25       296/320
(92 %)
0 diff
(100 %id)
AA383022 testis .d 1184 to 1446 263 to 1       263/263
(100 %)
0 diff
(100 %id)
AI969551 malignant melanoma, metastatic to lymphnode, skin .d 1203 to 1450 259 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 248/248
(100 %)
1 diff
(99.6 %id)
AA807629 germinal center B cell .d 1208 to 1467 291 to 31   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 261/261
(100 %)
1 diff
(99.7 %id)
AI365157 pooled germ cell tumors .d 1227 to 1448 229 to 8       222/229
(96 %)
0 diff
(100 %id)
BG941338 blood .d 1251 to 1448 222 to 24   AAA   199/215
(92 %)
0 diff
(100 %id)
DN918851   .d 1252 to 1441 191 to 1       191/192
(99 %)
7 diff
(96.4 %id)
EC548557 Prostate .d 1275 to 1381 1 to 103       103/103
(100 %)
4 diff
(96.2 %id)
AA713526 germinal center B cell .d 1299 to 1467 199 to 31   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 169/169
(100 %)
0 diff
(100 %id)
GD153202   .d 1315 to 1458 1 to 145       145/148
(97 %)
7 diff
(95.3 %id)
FN055248 breast carcinoma .d 1325 to 1441 2 to 118       117/118
(99 %)
5 diff
(95.8 %id)
DB466317 hippocampus .d 2011 to 2444 1 to 436   tiling clone,   436/436
(100 %)
11 diff
(97.5 %id)
CN264105 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2027 to 2365 33 to 372       340/372
(91 %)
6 diff
(98.4 %id)
BX101600 heart .d 2091 to 2798 1 to 709   tiling clone,   709/709
(100 %)
1 diff
(99.9 %id)
AW578854 colon .d 2210 to 2747 535 to 1       535/637
(83 %)
9 diff
(98.6 %id)
AW809596 stomach .d 2210 to 2531 325 to 3       323/328
(98 %)
0 diff
(100 %id)
AW856980 colon .d 2210 to 2611 102 to 503       402/504
(79 %)
7 diff
(98.7 %id)
AA233810 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2540 to 2961 1 to 422   fully sequenced,   422/422
(100 %)
0 diff
(100 %id)
AJ712761 bone marrow .d 2638 to 2884 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
AA325030 brain, cerebellum .d 2779 to 3056 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
AW962051   .d 2780 to 3321 1 to 538   tiling clone,   538/582
(92 %)
11 diff
(98.2 %id)
BQ430536 embryonal carcinoma, cell line, testis .d 2787 to 3298 40 to 552   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 513/552
(92 %)
6 diff
(99.0 %id)
AI143280 heart .d 2819 to 3301 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AI934863 anaplastic oligodendroglioma, brain .d 2847 to 3290 455 to 12       444/455
(97 %)
0 diff
(100 %id)
AI127328 heart .d 2859 to 3301 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AA233739 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2931 to 3302 372 to 1   fully sequenced,   372/372
(100 %)
0 diff
(100 %id)
BI090505 cervix .d 3449 to 4160 1 to 727   tiling clone,   727/728
(99 %)
34 diff
(95.4 %id)
AW504144 lymph .d 3561 to 3972 1 to 412       412/412
(100 %)
5 diff
(98.8 %id)
TI_154160265   .d 3567 to 4115 84 to 633       550/560
(98 %)
7 diff
(98.8 %id)
BU173290 eye, retinoblastoma .d 3832 to 4710 1 to 882       882/882
(100 %)
7 diff
(99.3 %id)
DA040708 bladder .d 4220 to 4764 2 to 546   capped   545/545
(100 %)
3 diff
(99.5 %id)
DB007788 cervix, tumor tissue .d 4648 to 5132 2 to 486   tiling clone, capped   485/485
(100 %)
0 diff
(100 %id)
BG433022 Kidney .d 5323 to 6035 2 to 724       723/728
(99 %)
19 diff
(97.4 %id)
AA354864   .d 5389 to 5790 1 to 405       405/405
(100 %)
4 diff
(99.1 %id)
DN601750 human embryonic stem cells .d 5587 to 6316 12 to 740       729/740
(98 %)
6 diff
(99.2 %id)
CD238787 Pituitary .d 5596 to 6330 1 to 735   tiling clone,   735/735
(100 %)
9 diff
(98.8 %id)
CD356581 Blood vessels - aorta, basilar and artery .d 5780 to 6363 1 to 593       593/778
(76 %)
37 diff
(95.3 %id)
AA243215 germinal center B cell .d 6078 to 6629 1 to 545       545/644
(84 %)
23 diff
(96.5 %id)
DB295973 bladder .d 6269 to 6809 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
AI434229 lymph node, lymphoma, follicular mixed small and largecell .d 6479 to 6809 390 to 60   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 331/331
(100 %)
3 diff
(99.1 %id)
AI867632 Prostate .d 6535 to 6761 1 to 227     Submitted on the opposite strand 227/227
(100 %)
0 diff
(100 %id)
BU176156 eye, retinoblastoma .d 6543 to 6803 60 to 318   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 259/318
(81 %)
6 diff
(98.2 %id)
AA399978   .e 1 to 473 1 to 472   tiling clone,   472/472
(100 %)
5 diff
(99.0 %id)
AA401350   .e 976 to 1435 462 to 3   tiling clone,   460/462
(99 %)
0 diff
(100 %id)
AW978057   .e 1382 to 1897 515 to 1   tiling clone, Submitted on the opposite strand 515/515
(100 %)
8 diff
(98.5 %id)
AA806774 germinal center B cell .e 1502 to 1914 413 to 1   tiling clone,   413/413
(100 %)
3 diff
(99.3 %id)
CB998831 Blood vessels - aorta, basilar and artery .f-u 1 to 531 1 to 545 A31S L33A R35V L36S G37L ... tiling clone,   545/735
(74 %)
23 diff
(96.9 %id)
AK124407 bladder Gene C16orf87, variant not shown       available from FLJ, This clone was ignored    
AW274284 pooled Gene C16orf87, variant not shown         Suspected internal deletion, this clone was ignored    
AV752990 Pituitary Gene C16orf87, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C